Spinal Muscular Atrophy [SMA] By PCR

This assessment uses a real-time polymerase chain reaction (PCR) method to detect genetic mutations in the SMN1 gene responsible for Spinal Muscular Atrophy (SMA), a progressive motor neuron disease. It aids in identifying the presence or absence of these mutations for carrier screening and effective management of the condition.